Reference number : 1480-2021-2022-Qrt4-0000136, amendment number : , agreement type : G, recipient legal name : Ottawa Hospital Research Institute | Ottawa Hospital Research Institute, recipient country : CA, recipient province : ON, recipient city : Ottawa | Ottawa, recipient postal code : K1H 8L6, program name english : Infectious Disease Prevention and Control, program name french : Prévention et contrôle des maladies infectieuses, program purpose english : To protect Canadians from infectious diseases (e.g., Human Immunodeficiency Virus (HIV), E. Coli and measles) by predicting, detecting, assessing and responding to outbreaks and new threats, and contribute to the prevention, control and reduction of the spread of infectious disease among Canadians., program purpose french : Protéger les Canadiens et les Canadiennes contre les maladies infectieuses (p. ex. le virus de l’immunodéficience humaine (VIH), l’E. coli et la rougeole) en prévoyant, en détectant, en évaluant et en traitant les éclosions et les nouvelles menaces, contribuer à la prévention, au contrôle et à la réduction de la propagation des maladies infectieuses chez les Canadiens et les Canadiennes., agreement title english : 2122-HQ-000074, agreement title french : 2122-HQ-000074, agreement number : 2122-HQ-000074, agreement value : 710860.0, agreement start date : 2021-04-01, agreement end date : 2023-03-31, description english : P003779, description french : P003779, expected results english : Not Available, expected results french : Non Disponible, additional information english : Belated Reporting (Funding of $710,860.00 actually awarded in Fiscal Year 2021-2022, Quarter 2), additional information french : Rapports tardifs (Financement de $710,860.00 attribué dans l'année financière 2021-2022, Trimestre 2), owner organization : phac-aspc, owner organization title : Public Health Agency of Canada | Agence de la santé publique du Canada